Regsurance

Endocrine Disruptor Assessment Under CLP: Key Challenges and How We Delivered a Robust, Regulator-Ready Outcome

Under CLP Delegated Regulation (EU) 2023/707, companies must assess whether substances meet criteria for endocrine disruption in humans (ED HH) or the environment (ED ENV). This post outlines how...

Understanding Dutch EPR: How RegSurance Helped a Multinational Client Save Costs

What Are My EPR Obligations in the Netherlands? If your company sells packaged products in the Dutch market, you probably need to follow EPR rules (Extended Producer Responsibility). That means...